Browse Good Future’s latest public updates, technical insights, and video content from one place.
40 items
A newly published MDPI paper showed that CSV+ CTCs measured on Good Future’s automated negative selection platform may support metastatic-risk stratification and recurrence monitoring in breast cancer.
The four-day exhibition concluded with active discussion, sharing, and professional exchange. Guests from multiple Southeast Asian countries visited the booth and showed strong interest in CTC technology and precision-medicine collaboration.
The 2024 Medical Fair Asia exhibition was held at the Sands Expo and Convention Center in Singapore in September. Good Future and the Inventec Appliances team demonstrated Chiline CATCH and other products and system solutions on site, attracting buyers and professionals from all over the world to stop and communicate.
We are pleased to announce that WellSpring will soon become Good Future's partner in Malaysia. The two parties will carry out more in-depth business cooperation and professional education and training, and explore new opportunities in the medical and health field.
![[Media Report] Exclusive/Inventec announces good news about smart medical care, executives reveal supply chains of these two countries are stuck](../assets/resources_local_2026-04-08_v001/resource_remote_028_2026-04-08_v001.jpg)
In response to the increasing demand for circulating tumor cells testing, Good Future, a subsidiary of Inventec, has joined hands with its group partner Inventec Appliances to create the circulating tumor cells automatic testing system "Chiline CATCH" and continues to expand into overseas markets.
5 items
See why CSV+ CTCs stood out in this study and what the results suggest for metastatic-risk stratification and recurrence monitoring.
See how CTCs enter the bloodstream from primary tumors and why circulating tumor cell testing is becoming an important reference for cancer risk assessment and follow-up.
From red blood cell removal and white blood cell identification to PowerMag magnetic-column processing, learn why Good Future uses negative selection to reduce loss caused by relying on a single surface marker.
From 2 mL blood collection and pre-processing to complete cell imaging reports, understand how Good Future strings together the process into readable test results.
7 videos
![Era TV [Discover New Taiwan] Program Special Report](https://img.youtube.com/vi/P77Pc0FAOsI/hqdefault.jpg)
Through the program's special format, you can quickly understand how Good Future brings circulating tumor cells testing into clinical and public communication scenarios.
A short introductory video that helps first-time viewers quickly understand the core concepts behind CTC testing.
From a clinical perspective, we discuss liquid biopsies and cancer screening, complementing imaging examinations, and the value of blood testing in tracking and early warning.